Vaginal Drug Delivery Systems PDF

Summary

This document provides an overview of vaginal drug delivery systems, including various types of vaginal rings, intrauterine devices (IUDs), the mechanism of action, and their potential applications. It also discusses the advantages and disadvantages of each type.

Full Transcript

1 used for Vaginal Drug Delivery systems → contraception , ↳ suitable for not systemic...

1 used for Vaginal Drug Delivery systems → contraception , ↳ suitable for not systemic menopause - thick C little % reaches the circulation] - menstruation , the membrane will shed t so its a local route Intravaginal Delivery Systems 2 contraception 1- menopause ¨ Vaginal rings reservoirs for a period of time - good long ¨ Intrauterine device (IUD) ¨ Vaginal Insert matrix > ¨ Vaginal gels → for short time couple hours ) ↳ can be used for controlledreleasebut Intravaginal delivery systems 3 ¨ Advantages inserts to some extent ¤ Self insertion and removal (e.g. rings) gets + + ¤ Continuous administration at an effective dose level (zero order release especially with rings) can be first order depends on → → the system ¤ Minimum systemic toxicity (local effect in the vagina) is oral ¤ Good patient compliance drugs circulate through whole ↳ sustained release to reach the body vagina and cause an ellett - side effects Types of Intravaginal delivery 4 systems I. Reservoir: drug surrounded by the polymeric membrane - through the membrane ¤ Membrane-controlled (diffusion design) C everything constant is → zero ¤ Constant rate of drug release polymer controls the rate - of release ¤ The required daily dose > → suspension → contrast suspension but in a liquid Hormonal Intrauterine DDS 15 ¨ Mirena ¤ Levonorgestrel (synthetic progestogen)-releasing intrauterine device ¤ Contains 52 mg (Mirena), 19.5 mg (Kyleena), or 13.5 mg (Skyla) ¤ Use: É¥¥* n Provides contraception for 5 years n Treats heavy periods - more ✓ flexible twisted foaraministration Intrauterine Progesterone DDS 16 ¨ Release in the uterine cavity provide a local rather than a systemic action. ¨ Readily absorbed into uterine epithelium Local → ¨ Systemic progesterone absorption is low ¨ Mechanism of action ¤ Increase the cervical mucus thickness (reduce sperm motility and survival). ¤ Changes the lining of the uterus (prevent implantation and egg fertilization). Intrauterine Progesterone DDS 17 determines the location d ¨ A small string hangs down from the IUD into the upper part of the vagina and is used to periodically check the device. ¤ A shorter-than-normal string can be a warning sign of an embedded (pushed in) IUD. Intrauterine Progesterone DDS 18 ¨ Contents → suspension ¤ Progesterone suspended in silicone oil formulation ¤ Barium sulfate to make radiopaque. ¤ Ethyl vinyl acetate (EVA) membrane surrounding the drug core controls the drug release. ¤ Titanium dioxide is added to EVA for white color ¨ At the end of the year, the device will contain excess progesterone à to maintain the thermodynamic activity of the drug reservoir b to maintain the zero order release Cto prevent the release from ) IUD Insertion 19 "" t " →wiupass wings device is pushed out cervix - adjust q the distance https://www.acog.org/programs/long-acting-reversible-contraception-larc/video-series/insertion/mirena IUD Insertion & Removal 20 Loom the cervix Intrauterine Progesterone DDS 21 ¨ Advantages , already foundin our body ¤ Using a natural hormone have side elleets ¤ Contains no estrogen - ¤ Using a T-shaped delivery that ensures ↳ n comfort sits in the uterus ( same shape nicely of it] n safety retained in place n retention < Locally to the site of action n êê irritation g ellects ( less side ¤ Confine hormonal action to the uterus compared to oral ] Failure rate range Failure rate range Method used (over 12 months) Method used (over 12 months) in clinical studies (%) in clinical studies (%) None 78–94 Oral contraceptive Spermicides 0.3–37 Estrogen and progestin 0–6 Periodic abstinence 13–35 Progestin only 1–10 Withdrawal 7–22 Injection 0–0.3 Medroxyprogesterone Cervical cap with spermicide 6–27 injection (90-day) Diaphragm with spermicide 2–23 Implants Levonorgestrel implant Condom without spermicide 2–14 Six capsules 0–0.09 IUD Progesterone-releasing 1.9–2.0 Two rods 0–0.2 Sterilization Copper-T 200 3.0–3.6 Female 0–8 Copper-T 200Ag 0–1.2 Male 0–0.5 Copper-T 220C 0.9–1.8 Copper-T 380A 0.5–0.8 Copper-T 380S 0.9 22 short-term Vaginal Inserts - administration 23 Cervidil® (Forest Lab) ¨ Composed of ¤ Slab: thick, flat, rectangular, buff- colored semitransparent polymeric hydrogel containing dinoprostone - ✓ (prostaglandin E2). dissolves reeeasingtredhlg d below the ¤ Retrieval system cervix CIM n A pouch of knitted polyester enclosing the slab vagina) n Attached to a long knitted strap used to retrieve the insert 0 once they d get hydrated - medication is here theyformedwyarogd Vaginal Insert 24 ¨ Uses ¤ For labor induction by initiation and/or continuation of cervical ripening “softening” (ê need for oxytocin) ¤ For second trimester abortion has limitations → ¨ The drug is dispersed in a polyethylene oxide matrix and released at a rate of about 0.3 mg/hr ¨ Mechanism: In moist environment à the unit absorbs water à swells and release dinoprostone in a controlled manner (swelling dissolving matrix design) ↳ if drug soluble then its by diffusion too is if drug is insoluble → dissolution only Vaginal Insert 25 ¨ Instructions ¤ 1 unit is inserted and removed upon induction of active labor ¤ The patient must be supine for 2 hr after administration ¨ Storage ¤ -20oC → forstability ¤ It is hygroscopic and properties of the drug may be altered if stored improperly Vaginal Gel → has to be biodegradable insoluble , polymer. 26 stones Crinone® Gel (Wyeth-Ayerst) ¨ A bioadhesive vaginal gel with extended action. ¨ Composition: ¤ Micronized progesterone ¤ Polycarbophil: water insoluble applicator < %swellable and adhesive polymer (fiber) soinsoluble → getis ¤ O/W emulsion of the drug (carrier polymer there vehicle). ¨ Mechanism: ¤ The polymer is insoluble in water à swells in the vagina à forms adhesi@ bioadhesive gel coating the walls of to the vagina. Mikasa ¤ The gel stays attached to the vaginal vagina walls for a few days as the progesterone is absorbed. Vaginal Gel 27 ¨ Uses ¤ Assist in reproduction in infertile women with progesterone deficiency (supplemental) – used twice daily ¤ Amenorrhea (absence of menstruation) – used every other day ¨ The female hormone progesterone is one of the hormones essential for preparation of the uterus for implantation and maintenance of a pregnancy. ¨ Applied using the supplied applicator.

Use Quizgecko on...
Browser
Browser